Skip to main content
Submitted by Dr S. Patel on 5 June 2018
Image: Stock photo of colon over white t-shirt and dark jeans set against a pink background

Colorectal cancer is the 4th most common cause of deaths related to cancer worldwide. Lynch syndrome or HNPCC is one of most common genetic causes of Colon cancer. Here are a few questions to better understand Lynch syndrome and how we can screen for it.

1. What is the Lynch syndrome? Which genes are involved?

Lynch Syndrome is also known as hereditary non-polyposis colorectal cancer or HNPCC. It has a genetic disposition, hence the term hereditary and is known to be associated or  the causative factor for various cancers including endometrial (second most common), ovarian, stomach, small intestine, hepatobiliary tract, upper urinary tract, skin and brain. It is an autosomal dominant genetic condition, which means that the gene defect can be passed down to the child even if only one parent has the mutated gene. Just one copy of the mutated gene is sufficient to develop cancer. Gene mutation is the permanent alteration in the DNA sequence that makes up a gene. Individuals who are carriers of such a mutated gene have a higher than normal chance of developing colorectal and the various cancers mentioned above, often at a young age. The early age onset, sporadic occurrence and right-sided colon lesions are discovered to be characteristic to Lynch syndrome. [Image result for lynch syndrome]

Genes currently known to be susceptible for Lynch syndrome include MLH1, MSH2, MSH6, PMS2, and EPCAM. 

2. What are signs and symptoms of Lynch syndrome?

It is recommended that one watch out for any signs and symptoms of colon and endometrial cancer. People with Lynch syndrome have the following risk factors:

  • Personal history of multiple gastrointestinal polyposis.
  • History of colon or gastrointestinal cancer at a younger age, especially before age of 50 years. 
  • Personal history of any of the following cancers: endometrial cancer, ovarian cancer, kidney cancer, stomach cancer, small intestine cancer, liver cancer, sweat gland cancer (sebaceous carcinoma), skin or brain.
  • Family history of colon or endometrial cancer under the age of 50.
  • 1 or more 1st or 2nd degree relative with colorectal or Lynch syndrome associated cancers. 
  • 2 or more 1st or 2nd degree relative with colorectal or Lynch syndrome associated cancers.

3. How common is the Lynch syndrome in India?

There are several inherited syndromes that can lead to increased risk of colon cancer, of which Lynch syndrome is the most common.

Statistics says that approximately 3 out of every 100 colon cancers are due by Lynch syndrome. In India, the annual incidence rate of Colon cancer is 4.4 per 100,000 in men and 3.9 per 100,000 in women. Approximately 5% of all colon cancers are attributed to genetic predisposition of Lynch syndrome.

4. Does Lynch syndrome affect every generation?

Yes. It does not skip generations. Both sexes can have Lynch syndrome and it may pass to any of their children.

5. How can a mother prevent passing on the gene to her child? How does preimplantation genetic diagnosis work for Lynch syndrome?

Mother can prevent passing unwanted genes to her child by doing preimplantation genetic diagnosis (PGD). Preimplantation genetic diagnosis is the procedure used to identify any genetic defects in an embryo. Embryos are usually made via the in vitro fertilization (IVF), tested at day 5 and only the desired embryos free of genetic problems are implanted into the uterus. Since the procedure is carried out before implantation, a couple has the choice of whether they want to start the pregnancy or not.

PGS or preimplantation genetic screening, is a procedure where all the embryos (produced by IVF) are checked for genetic diseases, so that the best embryo is then selected.

6. How is Lynch syndrome diagnosed?

After the tumor has been found via physical examination and colonoscopy, Lynch syndrome can be confirmed via tumor tissue testing from a biopsy. This is carried out for any individual who is suspected of having Lynch syndrome.

The two tumor tissue tests available are:

  • Microsatellite instability (MSI) test where a dye is used to check for missing proteins.
  • Immunohistochemistry (IHC) test determines instability in the DNA sequence.

Genetic testing of blood samples is commonly done to check for heritable mutations. Molecular genetic testing is necessary to confirm diagnosis of Lynch syndrome.

7. When and when should one start screening for it?

Families with Lynch syndrome and family members tested positive for gene mutation and those who have not been tested, should start colonoscopy screening during their early 20s, or 2 to 5 years younger than the youngest person in the family with a diagnosis (whichever is earlier). 

  • Colonoscopy should be done every 1 or 2 years. If there are any polyps present, they can be detected and removed. This helps find any early cancers too. People known to carry one of the gene mutations may also be given the choice of having surgery to remove most of the colon as a prophylactic measure.
  • Women are also recommended to inform their Gynecologist and get a transvaginal ultrasound or endometrial biopsy done every year after the age of 30.

8. If a person has been detected with the HPNCC genes, what preventive/ prophylactic measures are offered to the person?

  • Subtotal colectomy with ileorectal anastomosis (i.e. removal of subtotal colon and to join with rectum) and after that there is surveillance for rectum.
  • Or total colectomy with permanent ileostomy (removal of entire large colon and small bowel is put outside abdominal wall to pass stool and flatus permanently). This operation may be considered for prophylaxis in selected mismatch repair (MMR) gene mutation carriers.
  • Women may choose to have a hysterectomy (removal of the womb) or oophorectomy (removal of the ovaries). Such measures are recommended only after women have completed their families and do not prefer regular screening.

9. How much does genetic testing cost?

Testing of MLH1 is around 30,000/ rupees in India. If you have Lynch syndrome, each of your children have a 50% chance of acquiring the mutated gene. Children over the age of 18 can undergo genetic testing.

10. Can Lynch syndrome also cause Breast cancer?

The estimates of an increased risk of breast cancer in Lynch syndrome is relatively small compared with the increased risks observed for colorectal and endometrial cancers. 

It has a risk of around 12%.

11. What is the prognosis for Lynch syndrome-associated cancers?

Prognosis for Lynch Syndrome is,

  • Ten-year survival was 87% after any cancer.
  • 91% if the first cancer was colorectal.
  • 98% if endometrial and 89% if ovarian cancer..

References:

  1. Indian Council of Medical Research http://www.icmr.nic.in/guide/cancer/Colorectal/
  2. https://www.cancer.net/cancer-types/lynch-syndrome
  3. MedIndia, network for Health. https://www.medindia.net/patientinfo/lynch-syndrome.htm
  4. American Pregnancy Association. www.americanpregnancy.org

 

Community
Changed
Wed, 06/16/2021 - 13:44

Stories

  • FDA approves first use of novel immune system drug for cancer
    This new class of drugs unleashes the body's immune system to fight tumors. This seems to solve a century-old mystery of how cancerous cells manage to evade the body's immune system. The drug which Merck will sell under the name of Keytruda was approved by patients with advanced melanoma who have exhausted other therapies.  http://www.nytimes.com/2014/09/05/business/merck-wins-approval-of-novel-immune-system-drug-for-cancer.html?emc=eta1
  • Breast cancer specialist reports advance in treatment of triple-negative breast cancer that disproportionately affects younger women
    We hope that this means fewer women will relapse and die of their cancer, though the study is not large enough to prove this conclusively. Of the two agents we studied, we are more encouraged by the results from the addition of carboplatin, since it was associated with fewer and less concerning additional side effects than bevacizumab," Sikov explains.  William M. Sikov, a medical oncologist in the Breast Health Center and associate director for clinical research in the Program in Women's…
  • Do more for depressed cancer patients
    Clinical depression was much more prevalent among cancer patients than in the general population, where around 2% of people suffer from the mental illness at any point in time. Among cancer patients, clinical depression ranged from 13% in people with lung cancer to 6% in people with genitourinary cancer. The study's lead author Michael Sharpe, from Oxford University, said: "Major depression is really quite common in people with cancer and the perhaps surprising finding is that most of it goes…
  • Breast Cancer and Pregnancy - An Oncologist Shares
    Right and timely treatment can keep both mother and baby safe. Dr D.G. Vijay, Breast Cancer Specialist recalls a case of gestational breast cancer. Mrs. AK was overjoyed when her obstetrician told her that she was pregnant. She had been undergoing infertility treatment for a long time with no success. Only a few years ago, her mother had been diagnosed with breast cancer and she wished to see her grandchild before anything happened to her. But Mrs AK’s joy was short- lived as she…
  • Cancers can be prevented if people kept to a normal weight
     Excess weight linked to 10 different cancers Cancers have many causes – some of them genetic and some environmental. But the researchers, from the London School of Hygiene and Tropical Medicine (LSHTM) and the Farr Institute of Health Informatics, have taken account of all the other factors involved in order to come up with a good estimate of the actual number of cancers that could be prevented if people kept to a normal weight. http://www.theguardian.com/society/2014/aug/14/excess-weight…
  • New research from A*STAR for early detection and personalised treatment of Ovarian Cancer
    There are no early stage diagnostics for ovarian cancer and by the time they are discovered, they may not respond to standard cancer treatments.  But a new research from A*STAR's Institute of Medical Biology (IMB) and the Bioinformatics Institute (BII) have found new clues to early detection and personalized treatments of ovarian cancer, thus offering hope to millions of women who might be susceptible to it. Their findings were published online in Nature Cell Biology in July…
  • What your body may be trying to tell you
    Abnormally dry skin? Change in hair colour or shape of your nails? Even simple changes in the body may signify an underlying problem that you need to get checked out. By Dr Gita Mathai, paediatrician and family practitioner, shares tips to help you stay vigilant. The Skin should be a healthy colour.  • If it turns yellow, you may have jaundice.  • If it looks pale, get checked for anaemia. Here's how to manage iron-deficient anaemia. • Excessively cracked and…
  • Cancer survivor, 12, rewarded for selflessly volunteering to help other patients
    Cancer survivor Lam Yi-ning is only 12 years old. She was diagnosed with cancer when she was just seven. She underwent brain surgery, four chemotherapy sessions and 30 radiotherapy sessions. Despite frequent headaches and impaired vision, Lam spends a lot of time helping others through volunteer work. She is one of the top 10 "warriors" named by the Regeneration Society - and the youngest to be honoured in the group's 17-year history  http://www.scmp.com/news/hong-kong/article/…
  • Understanding the Role of Chemotherapy
    Chemotherapy can have different roles in treatment of cancer. It is important to understand the role of the chemotherapy prescribed for the patient. Dr. Kriti Mittal MD, MS Hematology and Medical Oncology explains the roles - curative, non-curative, palliative and adjuvant. It is important to understand the role of chemotherapy in the treatment of your cancer. In some cases of localized or locally advanced cancer that has not yet spread to distant organs, your health care provider may chose to…
  • Don’t shun them
    “Cancer patients in India are not just dealing with a major disease, they have to also deal with the stigma that comes with it” - Dr Purvish Parikh, Medical Oncologist and Hematologist; Health Activist and Editor in Chief at JASCAP Utsa Shah attends a cancer patients meet at Tata Memorial Hospital and experiences the truth of the statement. A middle-aged lady holding her 15-year-old kid’s hand, her eyes watery, said, “My kid is not allowed to play with other children.…